Curcuminoids for the management of hypertriglyceridaemia

Nature Reviews Cardiology

Volumn 11, Issue 2, 2014, Pages

  Sahebkar, Amirhossein ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CD36 ANTIGEN; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER TRANSFER PROTEIN; CURCUMIN; CURCUMINOID; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; FATTY ACID SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYPHENOL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; FATTY ACID BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN SENSITIVITY; LETTER; LIPID STORAGE; LIVER CELL DAMAGE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASE; GENE THERAPY; NOTE; RISK REDUCTION;

CARDIOVASCULAR DISEASES; GENETIC THERAPY; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; RISK REDUCTION BEHAVIOR; TRIGLYCERIDES;

EID: 84893641080     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2013.140-c1     Document Type: Letter

References (16)

1. Watts, G. F., Ooi, E. M. & Chan, D. C. Demystifying the management of hypertriglyceridaemia. Nat. Rev. Cardiol. 10, 648-661 (2013
2. Disilvestro, R. A., Joseph, E., Zhao, S. & Bosmer, J. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr. J. 11, 79 (2012
3. Mohammadi, A. et al. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: A randomized crossover trial. Phytother. Res. 27, 374-379 (2013
4. Na, L. X. et al. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: A double-blind, placebo-controlled trial. Mol. Nutr. Food Res. 57, 1569-1577 (2013
5. Shin, S. K., Ha, T. Y., McGregor, R. A. & Choi, M. S. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol. Nutr. Food Res. 55, 1829-1840 (2011
6. Um, M. Y., Hwang, K. H., Ahn, J. & Ha, T. Y. Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase. Basic Clin. Pharmacol. Toxicol. 113, 152-157 (2013
7. Sahebkar, A. Are curcuminoids effective C reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother. Res. http://dx.doi.org/10.1002/ptr.5045
8. Soetikno, V. et al. Curcumin ameliorates macrophage infiltration by inhibiting NF κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. Nutr. Metab. (Lond.) 8, 35 (2011
9. Panahi, Y., Sahebkar, A., Parvin, S. & Saadat, A. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Ann. Clin. Biochem. 49, 580-588 (2012
10. Chuengsamarn, S., Rattanamongkolgul, S., Luechapudiporn, R., Phisalaphong, C & Jirawatnotai, S. Curcumin Extract for Prevention of Type 2 Diabetes. Diabetes Care 35, 2121-2127 (2012
11. Nishiyama, T. et al. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK Ay mice. J. Agric. Food Chem. 53, 959-963 (2005
12. Gulcubuk, A et Al. Effects of Curcumin on Proinflammatory Cytokines and Tissue Injury in the Early and Late Phases of Experimental Acute Pancreatitis. Pancreatology 13, 347-354 (2013
13. Shin, S. K., Ha, T. Y., McGregor, R. A. & Choi, M. S. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol. Nutr. Food Res. 55, 1829-1840 (2011
14. Sahebkar, A. Systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels. Clin. Nutr. http://dx.doi.org/10.1016/j.clnu.2013.09.012
15. Cheng, A L. et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21, 2895-2900 (2001
16. Bisht, S. & Maitra, A. Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. Curr. Drug Discov. Technol. 6, 192-199 (2009